Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Antithrombin and antithrombotic effects of LB-30057 discussed at ISTH meeting

July 11, 2001

Novel anticoagulant targets surface-bound thrombin, may be preferable to heparin

July 11, 2001

Orally active gpIIb/IIIa antagonist shows broad-spectrum antiplatelet effects

July 11, 2001

Lilly patents new thrombin inhibitors with improved PK profile

July 10, 2001

Pharmacological profile of dual TxA2 antagonist and Tx synthase inhibitor discussed at ISTH

July 10, 2001

NCX-4016 has distinct pharmacological properties from acetylsalicylic acid

July 10, 2001

ISTH news: promising new factor VIIa inhibitor synthesized at Ajinomoto

July 10, 2001

FDA grants orphan drug status to Avigen's Coagulin-B

July 10, 2001

Mixed thrombin, factor Xa and platelet aggregation inhibition provided by BIBR-830ZW

July 10, 2001

CI-1031 may have a more favorable therapeutic index than enoxaparin

July 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...